XML 454 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements
16. Fair Value Measurements

 

The Company’s financial instruments consist of Level 1, Level 2 and Level 3 assets as of December 31, 2020 and 2019. As of December 31, 2020 and 2019, the Company’s cash and cash equivalents of $9,033,872 and $8,852,281, respectively, were Level 1 assets and included savings deposits, overnight investments, and other liquid funds with financial institutions.

 

Financial instruments measured at fair value during the year consisted of the following as of December 31, 2020 and 2019:

 

    Year Ended December 31, 2020  
    Fair Value    

Quoted Prices in Active Markets for Identical Assets

(Level 1)

   

Significant Other Observable Inputs

(Level 2)

   

Significant Unobservable Inputs

(Level 3)

 
Long-term debt:                                
12% Amended Senior Secured Notes   $ 52,556,401     $ -     $ 52,556,401     $ -  
Warrant derivative liabilities:                                
Strome Warrants   $ 704,707     $ -     $ -     $ 704,707  
B. Riley Warrants     443,188                -       -       443,188  
Total warrant derivative liabilities   $ 1,147,895     $ -     $ -     $ 1,147,895  

 

    Year Ended December 31, 2019  
    Fair Value    

Quoted Prices in Active Markets for Identical Assets

(Level 1)

   

Significant Other Observable Inputs

(Level 2)

   

Significant Unobservable Inputs

(Level 3)

 
Long-term debt:                                
12% Amended Senior Secured Notes   $ 44,009,745     $ -     $ 44,009,745     $ -  
Warrant derivative liabilities:                                
Strome Warrants   $ 1,036,687     $            -     $ -     $ 1,036,687  
B. Riley Warrants     607,513       -       -       607,513  
Total warrant derivative liabilities   $ 1,644,200     $ -     $ -     $ 1,644,200  
Embedded derivative liabilities   $ 13,501,000     $ -     $ -     $ 13,501,000  

 

The carrying value of the Company’s 12% Amended Senior Secured Notes (as defined below) approximates fair value based on current market interest rates for debt instruments of similar credit standing and, consequently, their fair values are based on Level 2 inputs.

 

The quantitative information utilized in the fair value calculation of the Level 3 liabilities are as follows:

 

The Company accounts for certain warrants and the embedded conversion features of the 12% Convertible Debentures (as described in Note 18) as derivative liabilities, which require the Company carry such amounts on its consolidated balance sheets as a liability at fair value, as adjusted at each reporting period-end.

 

The Company determined the fair value of the L2 Warrants, Strome Warrants and B. Riley Warrants (all as described in Note 21) utilizing the Black-Scholes valuation model as further described below. These warrants and the embedded conversion features are classified as Level 3 within the fair-value hierarchy. Inputs to the valuation model include the Company’s publicly-quoted stock price, the stock volatility, the risk-free interest rate, the remaining life of the warrants and debentures, the exercise price or conversion price, and the dividend rate. The Company uses the closing stock price of its common stock over an appropriate period of time to compute stock volatility. These assumptions are summarized as follows:

 

L2 Warrants – 2019 assumptions: Black-Scholes option-pricing; expected life: 3.75 years; risk-free interest rate: 1.56%; volatility factor: 130.46%; dividend rate: 0.0%; transaction date closing market price: $0.89; exercise price: $0.50.

 

Strome Warrants – 2020 assumptions: Black-Scholes option-pricing; expected life: 2.45; risk-free interest rate: 0.13%; volatility factor: 150.55%; dividend rate: 0.0%; transaction date closing market price: $0.60; exercise price: $0.50; and 2019 assumptions: Black-Scholes option-pricing; expected life: 3.45; risk-free interest rate: 1.62%; volatility factor: 144.56%; dividend rate: 0.0%; transaction date closing market price: $0.80; exercise price: $4.50.

 

B. Riley Warrants – 2020 assumptions: Black-Scholes option-pricing; expected life: 4.79 years; risk-free interest rate: 0.36%; volatility factor: 140.95%; dividend rate: 0.0%; transaction date closing market price: $0.60; exercise price: $1.00; and 2019 assumptions: Black-Scholes option-pricing; expected life: 5.80 years; risk-free interest rate: 1.76%; volatility factor: 127.63%; dividend rate: 0.0%; transaction date closing market price:$0.80; exercise price: $1.00.

 

The following table represents the carrying amount, valuation and roll-forward of activity for the Company’s warrants accounted for as a derivative liability and classified within Level 3 of the fair-value hierarchy as of and for the years ended December 31, 2020 and 2019:

 

    December 31,  
    2020     2019  
Carrying amount at beginning of year:                
L2 Warrants   $ -     $ 418,214  
Strome Warrants     1,036,687       587,971  
B. Riley Warrants     607,513       358,050  
Subtotal carrying amount at beginning of year     1,644,200       1,364,235  
Change in valuation of warrant derivative liabilities:                
L2 Warrants     -       316,972  
Strome Warrants     (331,980 )     448,716  
B. Riley Warrants     (164,325 )     249,463  
Subtotal change in valuation during the year     (496,305 )     1,015,151  
Exercise of warrants during the year:                
L2 Warrants     -       735,186  
Carrying amount at end of year:                
Strome Warrants     704,707       1,036,687  
B. Riley Warrants     443,188       607,513  
Carrying amount at end of year   $ 1,147,895     $ 1,644,200  

 

For the years ended December 31, 2020 and 2019, the change in valuation of warrant derivative liabilities recognized within other (expense) income on the consolidated statement of operations, as described in the above table of $496,305 and ($1,015,151), respectively. The L2 Warrants were fully exercised on a cashless basis during the year ended December 31, 2019, resulting in a $735,186 offset within additional paid-in capital on the consolidated statements of stockholders’ deficiency.

 

The following table represents the carrying amount, valuation and a roll-forward of activity for the conversion option features, buy-in features, and default remedy features, as deemed appropriate for each instrument (collectively the embedded derivative liabilities), for the 12% Convertible Debentures (refer to Note 18) accounted for as embedded derivative liabilities and classified within Level 3 of the fair-value hierarchy as of and for the years ended December 31, 2020 and 2019:

 

    December 31,  
    2020     2019  
Recognition of embedded derivative liabilities (conversion feature, buy-in feature, and default remedy feature):                
Carrying amount at beginning of year   $ 13,501,000     $ 7,387,000  
Issuance date of March 18, 2019     -       822,000  
Issuance date of March 27, 2019     -       188,000  
Issuance date of April 8, 2019     -       64,000  
Change in fair value of embedded derivative liabilities     (2,571,004 )     5,040,000  
Fair value of embedded derivative liabilities recorded within additional paid-capital upon conversion of 12% convertible debentures     (10,929,996 )     -  
Carrying amount at end of year   $ -     $ 13,501,000  

 

For the year ended December 31, 2020, the change in valuation of embedded derivative liabilities as described in the above table of $2,571,004 was recognized as other income on the consolidated statements of operations. For the year ended December 31, 2019, the change in valuation of embedded derivative liabilities as described in the above table of $5,040,000 was recognized as other expense on the consolidated statements of operations.

 

In addition, the fair value requirement at each period-end for the Series G Preferred Stock embedded conversion feature was no longer required for the year ended December 31, 2019 since it is not considered a derivative liability, therefore, the carrying amount of $72,563 as of January 1, 2018 was recognized as other income of $72,563 during the year ended December 31, 2019 on the consolidated statements of operations.

 

As a result of the conversion of certain 12% Convertible Debentures into shares of the Company’s common stock, the Company recorded the fair value of the embedded derivative liabilities of the conversion option features, buy-in features, and default remedy features of $10,929,996 within additional paid-in capital on the consolidated statements of stockholders’ deficiency (as further described in Note 18).

 

There have been no transfers in Level 1, Level 2, and Level 3 and no changes in valuation techniques for these assets or liabilities for the years ended December 31, 2020 and 2019.